DIMES - Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Subcellular Nephro-Vascular Diagnostic Program, Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Stem Cells. 2022 Dec 31;40(12):1071-1077. doi: 10.1093/stmcls/sxac066.
Mesenchymal stromal/stem cells (MSCs) have been identified in multiple human tissues, including the vascular wall. High proliferative potential, multilineage, and immunomodulatory properties make vascular MSCs promising candidates for regenerative medicine. Indeed, their location is strategic for controlling vascular and extra-vascular tissue homeostasis. However, the clinical application of MSCs, and in particular vascular MSCs, is still challenging. Current studies are focused on developing strategies to improve MSC therapeutic applications, like priming MSCs with stress conditions (hypoxia, nutrient deprivation) to achieve a higher therapeutic potential. The goal of the present study is to review the main findings regarding the MSCs isolated from the human vascular wall. Further, the main priming strategies tested on MSCs from different sources are reported, together with the experience on vascular MSCs isolated from healthy cryopreserved and pathological arteries. Stress induction can be a priming approach able to improve MSC effectiveness through several mechanisms that are discussed in this review. Nevertheless, these issues have not been completely explored in vascular MSCs and potential side effects need to be investigated.
间充质基质/干细胞(MSCs)已在多种人体组织中被鉴定出来,包括血管壁。高增殖潜能、多能性和免疫调节特性使血管 MSCs 成为再生医学有前途的候选者。事实上,它们的位置对于控制血管和血管外组织的内稳态具有战略意义。然而,MSC 的临床应用,特别是血管 MSC 的应用,仍然具有挑战性。目前的研究集中在开发策略来提高 MSC 的治疗应用,例如通过使 MSC 处于应激条件(缺氧、营养剥夺)下以获得更高的治疗潜力。本研究的目的是综述从人血管壁分离的 MSC 的主要发现。此外,还报告了不同来源的 MSC 所测试的主要预刺激策略,以及从健康冷冻保存和病理动脉分离的血管 MSC 的经验。应激诱导可以是一种预刺激方法,通过本文讨论的几种机制来提高 MSC 的有效性。然而,这些问题在血管 MSC 中尚未得到完全探讨,需要研究潜在的副作用。